Picture of Amneal Pharmaceuticals logo

AMRX Amneal Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapSuper Stock

Amneal Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

* Amneal Pharmaceuticals Inc  AMRX.OQ  reported quarterly
adjusted
earnings of 16 cents​​ per share for the quarter ended September
30, lower than the same quarter last year, when the company
reported EPS of 19 cents.  The mean expectation of four analysts
for the quarter was for earnings of 14 cents per share. Wall
Street expected results to range from 12 cents to 15 cents per
share.
    * Revenue rose 13.3% to $702.47 million from a year ago;
analysts
expected $696.80 million. 
    * Amneal Pharmaceuticals Inc's reported EPS for the quarter
was
breakeven results​.
    * The company reported a quarterly loss of $156 thousand.
    * Amneal Pharmaceuticals Inc shares had risen by 3.5% this
quarter and gained 41.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 9.1%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Amneal
Pharmaceuticals Inc is $10.00 
This summary was machine generated from LSEG data November 8 at
04:22 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.14           0.16           Beat
 Jun. 30 2024      0.14           0.16           Beat
 Mar. 31 2024      0.09           0.14           Beat
 Dec. 31 2023      0.09           0.14           Beat

Recent news on Amneal Pharmaceuticals

See all news